Across TCGA pan-cancer cohorts, LINC00632 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC00632’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00632 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00632 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

KIRC, LUAD, and BRCA are the cancer types where LINC00632 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00632 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	III,IV	+0.202	<.001	11	view →
LUAD	Female	All	+0.325	<.001	7	view →
BRCA	All	All	−0.458	<.001	6	view →
HNSC	All	All	+0.128	.001	6	view →
KIRP	Female	All	+0.211	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC00632 RNA expression & survival · all LINC00632 data types